Felicia Gerst1,2,3, Robert Wagner4,5,6, Gabriele Kaiser4,5,6, Madhura Panse5,6, Martin Heni4,5,6, Jürgen Machann4,5,7, Malte N Bongers7, Tina Sartorius5,6, Bence Sipos8, Falko Fend8, Christian Thiel9, Silvio Nadalin9, Alfred Königsrainer9, Norbert Stefan4,5,6, Andreas Fritsche4,5,6, Hans-Ulrich Häring4,5,6, Susanne Ullrich4,5,6, Dorothea Siegel-Axel4,5,6. 1. Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard Karls University of Tuebingen (IDM), Tuebingen, Germany. felicia.gerst@med.uni-tuebingen.de. 2. German Center for Diabetes Research (DZD), Tuebingen, Germany. felicia.gerst@med.uni-tuebingen.de. 3. Department of Internal Medicine IV, University Hospital Tuebingen, Otfried-Mueller Street 10, 72076, Tuebingen, Germany. felicia.gerst@med.uni-tuebingen.de. 4. Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard Karls University of Tuebingen (IDM), Tuebingen, Germany. 5. German Center for Diabetes Research (DZD), Tuebingen, Germany. 6. Department of Internal Medicine IV, University Hospital Tuebingen, Otfried-Mueller Street 10, 72076, Tuebingen, Germany. 7. Section of Experimental Radiology, Department of Diagnostic and Interventional Radiology, University Hospital Tuebingen, Tuebingen, Germany. 8. Department of General Pathology and Pathological Anatomy, University Hospital Tuebingen, Tuebingen, Germany. 9. Department of General, Visceral and Transplant Surgery, University Hospital Tuebingen, Tuebingen, Germany.
Abstract
AIMS/HYPOTHESIS: Obesity-linked ectopic fat accumulation is associated with the development of type 2 diabetes. Whether pancreatic and liver steatosis impairs insulin secretion is controversial. We examined the crosstalk of human pancreatic fat cells with islets and the role of diabetogenic factors, i.e. palmitate and fetuin-A, a hepatokine released from fatty liver. METHODS: Human pancreatic resections were immunohistochemically stained for insulin, glucagon, somatostatin and the macrophage/monocyte marker CD68. Pancreatic adipocytes were identified by Oil Red O and adiponectin staining. Primary pancreatic pre-adipocytes and differentiated adipocytes were co-cultured with human islets isolated from organ donors and the metabolic crosstalk between fatty liver and fatty pancreas was mimicked by the addition of palmitate and fetuin-A. Insulin secretion was evaluated by ELISA and RIA. Cytokine expression and secretion were assessed by RT-PCR and multiplex assay, respectively. Subcellular distribution of proteins was examined by confocal microscopy and protein phosphorylation by western blotting. RESULTS: In human pancreatic parenchyma, highly differentiated adipocytes were detected in the proximity of islets with normal architecture and hormone distribution. Infiltration of adipocytes was associated with an increased number of CD68-positive cells within islets. In isolated primary pancreatic pre-adipocytes and differentiated adipocytes, palmitate and fetuin-A induced IL6, CXCL8 and CCL2 mRNA expression. Cytokine production was toll-like receptor 4 (TLR4)-dependent and further accentuated in pre-adipocytes when co-cultured with islets. In islets, IL6 and CXCL8 mRNA levels were also increased by fetuin-A and palmitate. Only in macrophages within the isolated islets, palmitate and fetuin-A stimulated the production of the cytotoxic cytokine IL-1β. Palmitate, but not fetuin-A, exerted pro-apoptotic effects in islet cells. Instead, fetuin-A impaired glucose-induced insulin secretion in a TLR4-independent, but c-Jun N-terminal kinase- and Ca2+-dependent, manner. CONCLUSIONS/ INTERPRETATION: These results provide the first evidence that fetuin-A-mediated metabolic crosstalk of fatty liver with islets may contribute to obesity-linked glucose blindness of beta cells, while fatty pancreas may exacerbate local inflammation.
AIMS/HYPOTHESIS: Obesity-linked ectopic fat accumulation is associated with the development of type 2 diabetes. Whether pancreatic and liver steatosis impairs insulin secretion is controversial. We examined the crosstalk of humanpancreatic fat cells with islets and the role of diabetogenic factors, i.e. palmitate and fetuin-A, a hepatokine released from fatty liver. METHODS:Humanpancreatic resections were immunohistochemically stained for insulin, glucagon, somatostatin and the macrophage/monocyte marker CD68. Pancreatic adipocytes were identified by Oil Red O and adiponectin staining. Primary pancreatic pre-adipocytes and differentiated adipocytes were co-cultured with human islets isolated from organ donors and the metabolic crosstalk between fatty liver and fatty pancreas was mimicked by the addition of palmitate and fetuin-A. Insulin secretion was evaluated by ELISA and RIA. Cytokine expression and secretion were assessed by RT-PCR and multiplex assay, respectively. Subcellular distribution of proteins was examined by confocal microscopy and protein phosphorylation by western blotting. RESULTS: In humanpancreatic parenchyma, highly differentiated adipocytes were detected in the proximity of islets with normal architecture and hormone distribution. Infiltration of adipocytes was associated with an increased number of CD68-positive cells within islets. In isolated primary pancreatic pre-adipocytes and differentiated adipocytes, palmitate and fetuin-A induced IL6, CXCL8 and CCL2 mRNA expression. Cytokine production was toll-like receptor 4 (TLR4)-dependent and further accentuated in pre-adipocytes when co-cultured with islets. In islets, IL6 and CXCL8 mRNA levels were also increased by fetuin-A and palmitate. Only in macrophages within the isolated islets, palmitate and fetuin-A stimulated the production of the cytotoxic cytokine IL-1β. Palmitate, but not fetuin-A, exerted pro-apoptotic effects in islet cells. Instead, fetuin-Aimpaired glucose-induced insulin secretion in a TLR4-independent, but c-Jun N-terminal kinase- and Ca2+-dependent, manner. CONCLUSIONS/ INTERPRETATION: These results provide the first evidence that fetuin-A-mediated metabolic crosstalk of fatty liver with islets may contribute to obesity-linked glucose blindness of beta cells, while fatty pancreas may exacerbate local inflammation.
Authors: Paul Begovatz; Chrysi Koliaki; Katharina Weber; Klaus Strassburger; Bettina Nowotny; Peter Nowotny; Karsten Müssig; Jürgen Bunke; Giovanni Pacini; Julia Szendrödi; Michael Roden Journal: Diabetologia Date: 2015-03-05 Impact factor: 10.122
Authors: Ingrid Wernstedt Asterholm; Caroline Tao; Thomas S Morley; Qiong A Wang; Fernando Delgado-Lopez; Zhao V Wang; Philipp E Scherer Journal: Cell Metab Date: 2014-06-12 Impact factor: 27.287
Authors: Robert Wagner; Sabine S Eckstein; Hajime Yamazaki; Felicia Gerst; Jürgen Machann; Benjamin Assad Jaghutriz; Annette Schürmann; Michele Solimena; Stephan Singer; Alfred Königsrainer; Andreas L Birkenfeld; Hans-Ulrich Häring; Andreas Fritsche; Susanne Ullrich; Martin Heni Journal: Nat Rev Endocrinol Date: 2021-10-20 Impact factor: 43.330
Authors: Lisa S Chow; Robert E Gerszten; Joan M Taylor; Bente K Pedersen; Henriette van Praag; Scott Trappe; Mark A Febbraio; Zorina S Galis; Yunling Gao; Jacob M Haus; Ian R Lanza; Carl J Lavie; Chih-Hao Lee; Alejandro Lucia; Cedric Moro; Ambarish Pandey; Jeremy M Robbins; Kristin I Stanford; Alice E Thackray; Saul Villeda; Matthew J Watt; Ashley Xia; Juleen R Zierath; Bret H Goodpaster; Michael P Snyder Journal: Nat Rev Endocrinol Date: 2022-03-18 Impact factor: 47.564
Authors: Daniel M Tremmel; Austin K Feeney; Samantha A Mitchell; Peter J Chlebeck; Sierra A Raglin; Luis A Fernandez; Jon S Odorico; Sara D Sackett Journal: Am J Transplant Date: 2019-12-16 Impact factor: 8.086
Authors: Felicia Gerst; Benjamin A Jaghutriz; Harald Staiger; Anke M Schulte; Estela Lorza-Gil; Gabriele Kaiser; Madhura Panse; Sieglinde Haug; Martin Heni; Monika Schütz; Mandy Stadion; Annette Schürmann; Flavia Marzetta; Mark Ibberson; Bence Sipos; Falko Fend; Thomas Fleming; Peter P Nawroth; Alfred Königsrainer; Silvio Nadalin; Silvia Wagner; Andreas Peter; Andreas Fritsche; Daniela Richter; Michele Solimena; Hans-Ulrich Häring; Susanne Ullrich; Robert Wagner Journal: J Clin Endocrinol Metab Date: 2018-12-01 Impact factor: 5.958
Authors: María Lasierra Losada; Melissa Pauler; Niels Vandamme; Steven Goossens; Geert Berx; Moritz Leppkes; Harald Schuhwerk; Simone Brabletz; Thomas Brabletz; Marc P Stemmler Journal: Cell Death Discov Date: 2021-06-11